Quantum
QMCO
31.07
-2.40
-7.17%
Quantum
US · QMCO
#3054 by market cap
Listed 1970
31.07
-2.40
-7.17%
Live - 5344 symbols - heartbeat 555s ago
· 2026-10-08 07:40
Pre-market
30.26
-2.62%
After-hours
31.12
+0.16%
Overnight
30.70
-1.19%
- Market cap
- 1.22B
- P/E (TTM)i
- -2.36
- P/Bi
- -44.01
- EPSi
- -7.97
- Div yieldi
- 0.00%
- 52W posi
- 85%
Reader sentiment
Are you bullish or bearish on QMCO?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is -6.52, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +2.02% YoY
Margins
- Gross margin
- 36.86%
- Operating margin
- -5.86%
- Net margin
- -36.14%
Key ratios & quality
- Enterprise valuei
- 1.35B
- Altman Z-Scorei
- -6.52
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 402.68M | 402.95M | 349.58M | 383.43M | 422.08M | 311.60M | 274.06M | 279.58M |
| Gross profit | 167.61M | 172.51M | 150.75M | 157.64M | 143.26M | 124.89M | 109.83M | 103.04M |
| Selling & admin expenses | 134.68M | 113.98M | 96.95M | 108.21M | 113.79M | 112.44M | 116.28M | 95.93M |
| Research & development | 32.11M | 36.30M | 41.70M | 51.81M | 44.56M | 38.05M | 31.14M | 23.50M |
| Operating profit | 824.00K | 22.23M | 12.10M | -2.39M | -15.08M | -25.60M | -37.59M | -16.40M |
| Pretax profit | -40.42M | -4.41M | -35.22M | 39.70M | -16.43M | -40.58M | -114.27M | -100.04M |
| Tax | 2.38M | 803.00K | 239.00K | 1.34M | 1.94M | 711.00K | 821.00K | 1.01M |
| Net profit | -42.80M | -5.21M | -35.46M | 38.36M | -18.37M | -41.29M | -115.09M | -101.05M |
| Basic EPS | -23 | -3 | -17 | 13 | -4 | -9 | -22 | -8 |
| Diluted EPS | -23.14 | -2.80 | -16.60 | 13.00 | -4.00 | -8.68 | -22.35 | -7.97 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 61.26M | 64.29M | 62.72M | 74.59M | 77.99M | 80.80M |
| Gross profit | 24.24M | 22.71M | 23.55M | 28.93M | 27.85M | 31.72M |
| Selling & admin expenses | 27.77M | 26.22M | 22.83M | 23.02M | 23.86M | 20.64M |
| Research & development | 6.89M | 6.66M | 5.69M | 5.57M | 5.58M | 6.02M |
| Operating profit | -10.42M | -10.17M | -4.97M | 337.00K | -1.59M | 5.06M |
| Pretax profit | -7.60M | -16.98M | -46.30M | -27.25M | -9.50M | -154.58M |
| Tax | 146.00K | 223.00K | 157.00K | 590.00K | 38.00K | 710.00K |
| Net profit | -7.74M | -17.21M | -46.46M | -27.84M | -9.54M | -155.29M |
| Basic EPS | 0 | -2 | -3 | -2 | 0 | -7 |
| Diluted EPS | -0.13 | -1.87 | -3.49 | -2.03 | -0.39 | -7.06 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 154.29M | 135.83M | 156.07M | 145.20M | 153.06M | 131.78M | 102.81M | 112.49M |
| Cash & ST investments | 10.79M | 6.44M | 27.43M | 5.21M | 25.96M | 25.69M | 16.46M | 15.57M |
| Inventory | 37.51M | 49.70M | 47.89M | 57.80M | 44.75M | 27.54M | 22.43M | 16.10M |
| Total assets | 172.87M | 166.00M | 194.92M | 201.64M | 213.66M | 187.62M | 155.40M | 156.89M |
| Total current liabilities | 178.47M | 158.25M | 159.09M | 176.66M | 157.89M | 249.94M | 257.61M | 205.80M |
| Short-term debt | 1.65M | 7.32M | 1.85M | 6.10M | 6.36M | 110.36M | 123.94M | 55.61M |
| Long-term debt | 145.62M | 146.85M | 90.89M | 107.18M | 83.10M | -- | -- | 90.03M |
| Total liabilities | 372,651,000.00 | 364,520,000.00 | 307,169,000.00 | 345,374,000.00 | 298,026,000.00 | 309,113,000.00 | 319,768,000.00 | 355,749,000.00 |
| Total equity | -199.78M | -198.53M | -112.25M | -143.74M | -84.37M | -121.50M | -164.37M | -198.86M |
| Retained earnings | -697.95M | -703.16M | -738.62M | -767.73M | -786.09M | -827.38M | -942.47M | -1.04B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 102.81M | 118.44M | 90.13M | 103.62M | 112.49M | 148.72M |
| Cash & ST investments | 16.46M | 37.40M | 14.67M | 13.18M | 15.57M | 54.45M |
| Inventory | 22.43M | 20.03M | 18.93M | 17.63M | 16.10M | 15.20M |
| Total assets | 155.40M | 169.15M | 137.70M | 149.27M | 156.89M | 191.90M |
| Total current liabilities | 257.61M | 223.75M | 241.75M | 203.18M | 205.80M | 159.96M |
| Short-term debt | 123.94M | 96.71M | 99.63M | 52.76M | 55.61M | 877.00K |
| Long-term debt | -- | -- | -- | 75.87M | 90.03M | -- |
| Total liabilities | 319,768,000.00 | 283,540,000.00 | 298,196,000.00 | 333,501,000.00 | 355,749,000.00 | 219,722,000.00 |
| Total equity | -164.37M | -114.39M | -160.50M | -184.23M | -198.86M | -27.83M |
| Retained earnings | -942.47M | -959.68M | -1.01B | -1.03B | -1.04B | -1.20B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -16.86M | -1.18M | -767.00K | -33.73M | -4.89M | -10.16M | -23.61M | -37.86M |
| Depreciation & amortization | 4.27M | 4.29M | 5.70M | 9.42M | 10.12M | 9.31M | 5.60M | 5.28M |
| Free cash flow | -19.57M | -3.81M | -7.70M | -40.04M | -17.48M | -16.03M | -28.56M | -39.56M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | 98.09M | 1.76M | 67.15M | 0 | 15.83M | 75.25M |
| Ending cash balance | 16.86M | 12.27M | 33.14M | 5.49M | 26.18M | 25.86M | 16.60M | 16.23M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -3.27M | -16.89M | -15.60M | -4.95M | -418.00K | 947.00K |
| Depreciation & amortization | 1.16M | 1.03M | 825.00K | 799.00K | 2.63M | 1.17M |
| Free cash flow | -3.89M | -18.08M | -16.01M | -4.27M | -1.20M | 552.00K |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 15.83M | 66.99M | 81.00K | 5.04M | 3.14M | 94.64M |
| Ending cash balance | 16.60M | 37.55M | 15.33M | 13.84M | 16.23M | 54.59M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- | -- | -- |
| ROA %i | -22.79 | -3.08 | -19.65 | -16.28 | -18.46 | -20.58 | -67.11 | -64.71 |
| ROIC %i | -- | -- | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -4.80 | 5.20 | -2.20 | -5.11 | -6.16 | -8.18 | -33.08 | -28.06 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Current ratioi | 0.86 | 0.86 | 0.98 | 0.82 | 0.97 | 0.53 | 0.40 | 0.55 |
| Quick ratioi | 0.60 | 0.49 | 0.63 | 0.42 | 0.62 | 0.37 | 0.27 | 0.41 |
| Debt / assetsi | 85.19 | 99.39 | 51.68 | 61.09 | 46.63 | 63.95 | 85.50 | 98.04 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- | -- | -- |
| Interest coveragei | -0.92 | 0.83 | -0.28 | -1.60 | -2.41 | -1.69 | -3.84 | -3.64 |
| Revenue CAGR (3Y) %i | -5.42 | -6.51 | -7.22 | -1.62 | 1.56 | -3.76 | -10.59 | -12.83 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- |
| ROA %i | -67.11 | -65.68 | -97.53 | -62.55 | -64.71 | -132.46 |
| ROIC %i | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -33.08 | -32.04 | -46.58 | -27.63 | -28.06 | -74.46 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 0.40 | 0.53 | 0.37 | 0.51 | 0.55 | 0.93 |
| Quick ratioi | 0.27 | 0.38 | 0.24 | 0.36 | 0.41 | 0.76 |
| Debt / assetsi | 85.50 | 62.37 | 78.60 | 91.80 | 98.04 | 4.62 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- |
| Interest coveragei | -3.84 | -3.24 | -4.53 | -2.85 | -3.64 | -12.85 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Product revenue is the largest reported line at 66.67% of revenue, across 3 reported segments.
- Service and subscription follows at 30.53%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Product revenue66.67%
Service and subscription30.53%
Royalty2.80%
Quote time 2026-10-08 07:40:03 · For reference only, not investment advice and not tailored to your situation.